Literature DB >> 25668130

Involvement of the G-protein-coupled receptor 4 in RANKL expression by osteoblasts in an acidic environment.

Asuka Okito1, Ken-Ichi Nakahama2, Masako Akiyama3, Takashi Ono4, Ikuo Morita3.   

Abstract

Osteoclast activity is enhanced in acidic environments following systemic or local inflammation. However, the regulatory mechanism of receptor activator of NF-κB ligand (RANKL) expression in osteoblasts under acidic conditions is not fully understood. In the present paper, we detected the mRNA expression of the G-protein-coupled receptor (GPR) proton sensors GPR4 and GPR65 (T-cell death-associated gene 8, TDAG8), in osteoblasts. RANKL expression and the cyclic AMP (cAMP) level in osteoblasts were up-regulated under acidic culture conditions. Acidosis-induced up-regulation of RANKL was abolished by the protein kinase A inhibitor H89. To clarify the role of GPR4 in RANKL expression, GPR4 gain and loss of function experiments were performed. Gene knockdown and forced expression of GPR4 caused reduction and induction of RANKL expression, respectively. These results suggested that, at least in part, RANKL expression by osteoblasts in an acidic environment was mediated by cAMP/PKA signaling resulting from GPR4 activation. A comprehensive microarray analysis of gene expression of osteoblasts revealed that, under acidic conditions, the phenotype of osteoblasts was that of an osteoclast supporting cell rather than that of a mineralizing cell. These findings will contribute to a molecular understanding of bone disruption in an acidic environment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acidosis; Cyclic AMP; GPR4; RANKL

Mesh:

Substances:

Year:  2015        PMID: 25668130     DOI: 10.1016/j.bbrc.2015.01.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  A role for G protein-coupled receptor 137b in bone remodeling in mouse and zebrafish.

Authors:  K Urso; J Caetano-Lopes; P Y Lee; J Yan; K Henke; M Sury; H Liu; M Zgoda; C Jacome-Galarza; P A Nigrovic; J Duryea; M P Harris; J F Charles
Journal:  Bone       Date:  2019-06-05       Impact factor: 4.398

Review 2.  The Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review.

Authors:  Dylan L Petkus; Laura E Murray-Kolb; Mary Jane De Souza
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

Review 3.  Iron and 25-hydroxyvitamin D in postmenopausal women with osteoporosis.

Authors:  Nasser M Al-Daghri; Sobhy Yakout; Afnan Ghaleb; Syed Danish Hussain; Shaun Sabico
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 4.  Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis.

Authors:  Laura Toxqui; M Pilar Vaquero
Journal:  Nutrients       Date:  2015-04-02       Impact factor: 5.717

5.  Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss.

Authors:  Donatella Granchi; Elena Torreggiani; Annamaria Massa; Renata Caudarella; Gemma Di Pompo; Nicola Baldini
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

6.  Acidosis Activates Endoplasmic Reticulum Stress Pathways through GPR4 in Human Vascular Endothelial Cells.

Authors:  Lixue Dong; Elizabeth A Krewson; Li V Yang
Journal:  Int J Mol Sci       Date:  2017-01-27       Impact factor: 5.923

7.  Involvement of the G-Protein-Coupled Receptor 4 in the Increased Expression of RANK/RANKL/OPG System and Neurotrophins by Nucleus Pulposus Cells under the Degenerated Intervertebral Disc-Like Acidic Microenvironment.

Authors:  Hao Li; Huafei Liu; Ning Zhang; Zemin Zhu
Journal:  Biomed Res Int       Date:  2020-05-29       Impact factor: 3.411

8.  Can GPR4 Be a Potential Therapeutic Target for COVID-19?

Authors:  Li V Yang; Karen A Oppelt; Mary Jane Thomassen; Mona A Marie; Shayan Nik Akhtar; Justin D McCallen
Journal:  Front Med (Lausanne)       Date:  2021-01-21

9.  The proton-activated G protein-coupled receptor GPR4 regulates the development of osteoarthritis via modulating CXCL12/CXCR7 signaling.

Authors:  Rong Li; Zijing Guan; Shuyan Bi; Fanhua Wang; Liang He; Xin Niu; Yu You; Yuwei Liu; Yi Ding; Stefan Siwko; Ning Wang; Ziming Zhang; Yunyun Jin; Jian Luo
Journal:  Cell Death Dis       Date:  2022-02-14       Impact factor: 9.685

Review 10.  Physiological relevance of proton-activated GPCRs.

Authors:  Pedro H Imenez Silva; Carsten A Wagner
Journal:  Pflugers Arch       Date:  2022-03-05       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.